Markers of angiogenesis (CD31, CD34, rCBV) and their prognostic value in low-grade gliomas;Markery angiogenezy (CD31, CD34, rCBV) w utkaniu wysoko zróżnicowanych glejaków mózgu oraz ich wartość rokownicza

Neurologia i Neurochirurgia Polska

Volumn 47, Issue 4, 2013, Pages 325-331

  Majchrzak, Krzysztof ^a   Kaspera, Wojciech ^a   Szymaś, Janusz ^b   Bobek Billewicz, Barbara ^c   Hebda, Anna ^c   Majchrzak, Henryk ^a  

^a Sosnowcu lskiego Uniwersytetu Medycznego w Katowicach   (Poland)

^b Uniwersytetu Medycznego w Poznaniu   (Poland)

^c Instytutu im M Skodowskiej Curie Oddzia w Gliwicach   (Poland)

Author keywords

CD31; CD34; Low grade gliomas; Outcome; rCBV

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN;

ANGIOGENESIS; ARTICLE; BRAIN BLOOD VOLUME; CANCER PROGNOSIS; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ECHO PLANAR IMAGING; ENDOTHELIUM CELL; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MICROSCOPY; MICROVASCULATURE; OVERALL SURVIVAL; PERFUSION WEIGHTED IMAGING; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TUMOR RECURRENCE;

EID: 84881527713     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2013.36757     Document Type: Article

References (17)

1. Pusztaszeri M.P., Seelentag W., Bosman F.T. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fl-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395.
2. Aroca F., Renaud W., Bartoli C., et al. Expression of PECAM 1/CD31 isoforms in human brain gliomas. J Neurooncol 1999; 43: 19-25.
3. Khattab A.Z., Ahmed M.I., Fouad M.A., et al. Significance of p53 and CD31 in astrogliomas. Med Oncol 2009; 26: 86-92.
4. Assimakopoulou M., Sortiropoulou G., Maraziotis T., et al. Microvessel density in brain tumors. Anticancer Res 1997; 17: 4747-4753.
5. Santarelli J.G., Udani V., Jung Y.C., et al. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium vessels in the mouse brain. Neurosurgery 2006; 59: 374-382.
6. Aronen H.J., Gazit I.E, Louis D.N., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 19: 41-51.
7. Shin J.H., Lee H.K., Kwun B.D., et al. Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002; 179: 783-789.
8. Law M., Yang S., Wang H., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998.
9. Cha S., Johnson G., Wadghiri Y.Z., et al. Dynamic, contrasten hanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003; 49: 848-855.
10. Saito T., Yamasaki F., Kajiwara Y., et al. Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors. Eur J Radiol 2012; 81: 1863-1869.
11. Majchrzak K., Kaspera W., Bobek-Billewicz B., et al. The assesment of prognostic factors in surgical treatment of low grade gliomas. A prospective study. Clin Neurol Neurosurg 2012; 114: 1135-1144.
12. Law M., Oh S., Johnson G., et al. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 2006; 58: 1099-1107.
13. Birner P., Piribauer M., Fischer I., et al. Vascular patterns in glioblastoma influence clinical outcome and variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol 2003; 13: 133-143.
14. Lewelt A., Dziecio J., Guziñska-Ustymowicz K., et al. Angiogenesis in gliomas. Folia Histochem Cytobiol 2008; 46: 69-72.
15. Yao Y., Kubota T., Takeuchi H., et al. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an antiCD31 monoclonal antibody. Neuropathology 2005; 25: 201-206.
16. Wesseling P., Ruiter D., Burger P.C. Angiogenesis in brain tumors: pathobiological and clinical aspects. J Neurooncol 1997; 32: 253-265.
17. Izycka E., Rzepko R., Borowska-Lehman J.x, /xetalet al/etal. Angiogenesis in glioblastoma - analysis of intensity and relations to chosen clinical data. Folia Neuropathol 2003; 41: 15-21.